Prophylactic use of the Arabin cervical pessary in fetuses with severe congenital diaphragmatic hernia treated by fetoscopic endoluminal tracheal occlusion (FETO): Preliminary experience

Oana Dobrescu, Mieke M. Cannie, Anne Gael Cordier, Carlota Rodó, Isabella Fabietti, Alexandra Benachi, Elena Carreras, Nicola Persico, Ivan Hurtado, Léonardo Gucciardo, Jacques C. Jani

Research output: Contribution to journalArticleResearchpeer-review

5 Citations (Scopus)

Abstract

© 2015 John Wiley & Sons, Ltd. Objective: The aim of this study was to describe whether the prophylactic use of a cervical pessary decreases the rate of premature birth in congenital diaphragmatic hernia (CDH) fetuses treated with fetoscopic tracheal occlusion (FETO). Methods: The study concerns a consecutive series of cases with CDH and FETO and a group of CDH without FETO. In a subgroup of the FETO group, a prophylactic cervical pessary was inserted the day following the procedure. Gestational age (GA) at birth was the primary outcome. Results: Fifty-nine fetuses with FETO and 47 expectantly managed were included. The last 15 FETO had a cervical pessary inserted. The median GA at delivery in the FETO group with pessary was 35.1weeks and was not different from that in the FETO group without a pessary (34.3weeks; p=0.28) but was below that in the expectantly managed group (38.3weeks; p<0.001). Conclusion: Early results suggest that prophylactic use of an Arabin cervical pessary does not prolong gestation of CDH fetuses treated with FETO.
Original languageEnglish
Pages (from-to)81-87
JournalPrenatal Diagnosis
Volume36
Issue number1
DOIs
Publication statusPublished - 1 Jan 2016

Fingerprint Dive into the research topics of 'Prophylactic use of the Arabin cervical pessary in fetuses with severe congenital diaphragmatic hernia treated by fetoscopic endoluminal tracheal occlusion (FETO): Preliminary experience'. Together they form a unique fingerprint.

  • Cite this